Sweet succession: Gonzalez, patent thickets and his triumph over biosimilars

This week Lori, Greg and Tyler discuss AbbVie: how longtime CEO Richard Gonzalez navigated Humira's LOE, his victorious retirement announcement, and the future of biosimilars.

Also discussed: Earlybird Health's $186m VC fund; and definitely not the IRA.